Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1α metabotropic glutamate receptor

被引：47
|
作者：
Hermans, E [1 ]
Nahorski, SR [1 ]
Challiss, RAJ [1 ]
机构：
[1] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
来源：
NEUROPHARMACOLOGY | 1998年 / 37卷 / 12期
基金：
英国惠康基金;
关键词：
glutamate; mGlu1 alpha receptor; phosphoinositide hydrolysis; non-competitive antagonist; CPCCOEt;
D O I：
10.1016/S0028-3908(98)00132-4
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
In transfected CHO cells expressing the human metabotropic glutamate receptor mGlu1 alpha, 7- hydroxyimino)cyclopropan[b]chromen-1a-carboxylic acid ethylester (CPCCOEt) was found to antagonize L-quisqualate-induced phosphoinositide hydrolysis in a non-competitive and reversible manner (apparent pK(i) value, 4.76 +/- 0.18: It = 3. This suggests that CPCCOEt antagonizes type Ir metabotropic glutamate receptor activation by interacting with a site distinct from the agonist binding site. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1645 / 1647
页数：3
相关论文
共 50 条
  • [31] 1,3-Dihydro-benzo[b][1,4]Diazepin-2-one Derivatives as Potent Non-Competitive Metabotropic Glutamate Receptor 2/3 Antagonists
    Woltering, T. J.
    Wichmann, J.
    Goetschi, E.
    Huwyler, J.
    Knoflach, F.
    Ballard, T. M.
    Gatti, S.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 67 - 67
  • [32] Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models
    Kohara, Atsuyuki
    Nagakura, Yukinori
    Kiso, Tetsuo
    Toya, Takashi
    Watabiki, Tomonari
    Tamura, Seiji
    Shitaka, Yoshitsugu
    Itahana, Hirotsune
    Okada, Masamichi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 571 (01) : 8 - 16
  • [33] COMPETITIVE ANTAGONISM BY PHENYLGLYCINE DERIVATIVES AT TYPE-1 METABOTROPIC GLUTAMATE RECEPTORS
    FERRAGUTI, F
    CAVANNI, P
    EISTETTER, H
    SALVAGNO, C
    RATTI, E
    TRIST, DG
    MOLECULAR AND CELLULAR NEUROSCIENCE, 1994, 5 (03) : 269 - 276
  • [34] Molecular characterization and localization of human metabotropic glutamate receptor type 4
    Makoff, A
    Lelchuk, R
    Oxer, M
    Harrington, K
    Emson, P
    MOLECULAR BRAIN RESEARCH, 1996, 37 (1-2): : 239 - 248
  • [35] Molecular characterization and localization of human metabotropic glutamate receptor type 3
    Makoff, A
    Volpe, F
    Lelchuk, R
    Harrington, K
    Emson, P
    MOLECULAR BRAIN RESEARCH, 1996, 40 (01): : 55 - 63
  • [36] Neuroprotection by memantine, a non-competitive antagonist after traumatic brain injury NMDA receptor in rats
    Rao, VLR
    Dogan, A
    Todd, KG
    Bowen, KK
    Dempsey, RJ
    BRAIN RESEARCH, 2001, 911 (01) : 96 - 100
  • [37] The non-competitive NMDA receptor antagonist MK801 influences the consolidation of catalepsy sensitization
    Riedinger, K.
    Schmidt, W. J.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S50 - S50
  • [38] Synthesis and structure-activity relationships of novel non-competitive AMPA receptor antagonist.
    Kawano, K
    Nagato, S
    Ueno, K
    Norimine, Y
    Ito, K
    Hanada, T
    Ueno, M
    Hatakeyama, S
    Ohgoh, M
    Amino, H
    Yamauchi, T
    Tokuhara, N
    Smith, T
    Groom, A
    Rivers, L
    Nishizawa, Y
    Yonaga, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U209 - U209
  • [39] Modulation of the expression of the human type 1 α metabotropic glutamate receptor in Chinese hamster ovary cells
    Hermans, E
    Challiss, RAJ
    Nahorski, SR
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 : U72 - U72
  • [40] Non-competitive pharmacological antagonism at the rabbit B1 receptor
    Larrivée, JF
    Gera, L
    Houle, S
    Bouthillier, J
    Bachvarov, DR
    Stewart, JM
    Marceau, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (05) : 885 - 892
12345